• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Prothrombin Complex Concentrates are Superior to Fresh Frozen Plasma for Urgent Warfarin Reversal

October 6, 2016

Disposable plastic medical syringe and color coded tubes containing synthetic blood samples. Blue top - buffered sodium citrate. Lavender top - K2-EDTA anticoagulant

Although warfarin is a common anticoagulant used to prevent blood clots and strokes, it is associated with major bleeding episodes that occasionally need to be stopped quickly. Urgent surgery patients who are taking warfarin also need the anticoagulant effects of warfarin to be reversed quickly, which is accomplished by either (1) transfusing fresh frozen plasma or (2) giving prothrombin complex concentrates. A recent systematic review and meta-analysis incorporating 13 studies compared the clinical outcomes of both strategies for urgent warfarin reversal. Compared to patients who received fresh frozen plasma, patients treated with prothrombin complex concentrates had a significant reduction in all-cause mortality (odds ratio = 0.56; 95% CI, 0.37—0.84; p=0.0006), faster international normalized ratio reduction and correction, and reduced volume overload.  Many of the included studies were at moderate or serious risk of bias, thus further research is needed to confirm these conclusions.

Reference:

  1. Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, Crowther M. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb Haemost 2016;116.

 

Filed Under

  • Coagulation & Plasma Transfusion
  • News

Recommended

  • Randomized Trial Demonstrates that Hydroxyurea is Not Effective as Transfusion in Preventing Strokes

  • FDA Recommends Screening Blood for Zika Virus in South Florida after Reports of Local Transmission

  • Gene Therapy for Hemophilia A Decreases Bleeding

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley